--- title: "Bon Natural Life (BON) news: offering and buyback" url: "https://aibio.space/companies/bon-natural-life/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BON offering and buyback news: Bon Natural Life's interim results reflect 1-for-25 share consolidation and offering." --- BON Bon Natural Life Limited NASDAQ · China # Bon Natural Life (BON) news BON offering and buyback news Listings · 2025-09-29 ## [Bon Natural Life's interim results reflect 1-for-25 share consolidation and offering](https://aibio.space/news/bon-natural-lifes-interim-results-reflect-1-25-share-consolidation/) Bon Natural Life's unaudited interim statements for the six months to March 31, 2025, filed in a Form 6-K on September 29, 2025, reflect a 1-for-25 share consolidation and net proceeds of $10,543,805 from a public offering of Class A ordinary shares. Cash rose from $80,466 to $8,894,053 over the period. ## Latest Bon Natural Life news 1. 2025-08-05 Listings [Bon Natural Life says Nasdaq closed bid price matter, with one-year panel monitor](https://aibio.space/news/bon-natural-life-says-nasdaq-closed-bid-price-matter-one-year-panel/) Bon Natural Life says Nasdaq has closed its bid price matter after the Hearings Panel decision, but the company stays under a one-year Discretionary Panel Monitor. The Nasdaq confirmation came on July 29, 2025, and the company reported it in a Form 6-K dated August 4, 2025. 2. 2025-06-03 Financings [Bon Natural Life announces share buyback of up to $1.0 million](https://aibio.space/news/bon-natural-life-announces-share-buyback-up-1-0-million/) Bon Natural Life's board approved a share repurchase of up to $1.0 million of its Class A ordinary shares, to be bought in the open market by TradeUp Securities as exclusive agent. The company says it is not obliged to buy any particular number of shares and may suspend the program at any time. ## Bon Natural Life at a glance - **Ticker**: BON - **Listing**: NASDAQ - **Country**: China - **Cash, Sep 30, 2025**: $6.3 million ### Related companies - [Zhejiang Hengtong Holding Co.](https://aibio.space/companies/zhejiang-hengtong/) SSE: 600226 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) HKEX: 1779 - [Shanghai Rightongene Biotechnology Co.](https://aibio.space/companies/shanghai-rightongene-biotechnology/) SSE: 688217 - [Anhui Huaheng Biotechnology Co.](https://aibio.space/companies/anhui-huaheng-biotechnology/) SSE: 688639 - [Walvax Biotechnology Co.](https://aibio.space/companies/walvax-biotechnology/) SZSE: 300142 - [IMPACT Therapeutics](https://aibio.space/companies/impact-therapeutics/) HKEX: 7630 - [Anhui Wanbang Pharmaceutical Technology Co.](https://aibio.space/companies/anhui-wanbang-pharmaceutical-technology/) SZSE: 301520 - [R&G PharmaStudies Co.](https://aibio.space/companies/r-g-pharmastudies/) SZSE: 301333 ### Also on NASDAQ - [SL Science Holding](https://aibio.space/companies/sl-science/) SLBT - [Xeris Biopharma Holdings](https://aibio.space/companies/xeris-biopharma/) XERS - [aTyr Pharma](https://aibio.space/companies/atyr-pharma/) ATYR - [INTEGRA LIFESCIENCES HOLDINGS CORP](https://aibio.space/companies/integra-lifesciences/) IART - [OPKO HEALTH, INC.](https://aibio.space/companies/opko-health/) OPK - [Soligenix](https://aibio.space/companies/soligenix/) SNGX ## Bon Natural Life annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Revenue | [$18.7 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | [$23.8 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | | Research and development | [$754,193](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | [$1.6 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | | Net income (loss) | [-$2.0 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | [$398,172](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | | Cash from operations | [$141,115](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | [-$7.7 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | | Cash and equivalents | [$6.3 million](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/) | [$80,466](https://www.sec.gov/Archives/edgar/data/1816815/000164117225004960/) | Latest balance sheet, Sep 30, 2025 (20-F): cash and equivalents $6.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Bon Natural Life Has Bon Natural Life raised money recently? Our latest story on this, dated Sep 29, 2025: "Bon Natural Life's interim results reflect 1-for-25 share consolidation and offering". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/bon-natural-lifes-interim-results-reflect-1-25-share-consolidation/). Does Bon Natural Life have a share buyback? Our latest story on this, dated Jun 3, 2025: "Bon Natural Life announces share buyback of up to $1.0 million". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/bon-natural-life-announces-share-buyback-up-1-0-million/). What is the ticker symbol of Bon Natural Life? Bon Natural Life Limited trades under the ticker BON on NASDAQ. Where is Bon Natural Life listed? Bon Natural Life Limited is listed on NASDAQ. What is the SEC CIK of Bon Natural Life? The SEC Central Index Key (CIK) for Bon Natural Life Limited is 1816815. Its filings are on SEC EDGAR. How many shares does Bon Natural Life have outstanding? 3,970,558 shares as of 2024-09-30, per the cover page of its 20-F filed 2025-01-28. Which country or territory is Bon Natural Life listed under? Our directory records Bon Natural Life Limited under China. What does Bon Natural Life do? Our directory classifies Bon Natural Life Limited as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Bon Natural Life? The ISIN recorded for Bon Natural Life Limited is KYG144922047. Does aibio.space cover Bon Natural Life? aibio.space lists Bon Natural Life Limited among 2,820 public biotech companies and publishes its news here as stories appear. Where is Bon Natural Life incorporated? SEC records list its state or country of incorporation as E9. What was Bon Natural Life's revenue last year? $18.7 million for the fiscal year ended Sep 30, 2025, as reported to the SEC. Is Bon Natural Life profitable? Bon Natural Life Limited reported a net loss of $2.0 million for the fiscal year ended Sep 30, 2025, and generated $141,115 of cash from operations, per its annual report to the SEC. How much does Bon Natural Life spend on research and development? $754,193 in the fiscal year ended Sep 30, 2025, per its annual report. How much cash does Bon Natural Life have? $6.3 million in cash at Sep 30, 2025, per its 20-F. ## Investor discussion: Bon Natural Life Members talk about Bon Natural Life (BON). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Bon Natural Life, newest first. Each line links the filing it comes from. 1. 2025-12-10 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315225027001/ex99-1.htm) 2. 2025-09-29 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315225015913/ex99-1.htm) 3. 2025-08-05 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225022118/form6-k.htm) 4. 2025-07-11 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225018700/form6-k.htm) 5. 2025-06-03 Financings Announced a share repurchase program. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225013373/ex99-1.htm) 6. 2025-05-05 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225008442/ex99-1.htm) 7. 2025-04-23 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225005801/form6-k.htm) 8. 2025-04-03 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000164117225002494/ex99-1.htm) 9. 2025-03-17 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315225010651/ex99-1.htm) 10. 2025-02-28 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315225008630/form6-k.htm) 11. 2025-01-06 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315225000407/ex99-1.htm) 12. 2024-11-19 Financings Filed a registration statement for a share offering. SEC Form F-1. [Source](https://www.sec.gov/Archives/edgar/data/1816815/000149315224046762/formf-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:BON on TradingView](https://www.tradingview.com/symbols/NASDAQ-BON/). ## SEC filings and registration - **SEC name**: Bon Natural Life Ltd - **CIK**: 1816815 - **Industry (SIC)**: Medicinal Chemicals & Botanical Products (2833) - **US tickers**: BON (Nasdaq) - **State or country of incorporation**: E9 - **Fiscal year ends**: September 30 - **Filer category**: Non-accelerated filer
Emerging growth company - **Business address**: ROOM 601, BLOCK C, GAZELLE VALLEY, NO.69, SHAANXI, China, 710076 - **Phone**: 0086-29-88346301 - **Shares outstanding**: 3,970,558 as of 2024-09-30 (20-F filed 2025-01-28) ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315226043944/form6-k.htm) filed 2026-09-23 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315226011448/form6-k.htm) filed 2026-03-19 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315226006960/form6-k.htm) filed 2026-02-17 - [20-F](https://www.sec.gov/Archives/edgar/data/1816815/000149315226003270/form20-f.htm) filed 2026-01-23 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315225027001/form6-k.htm) filed 2025-12-10 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315225024913/form6-k.htm) filed 2025-11-25 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315225022626/form6-k.htm) filed 2025-11-14 - [6-K](https://www.sec.gov/Archives/edgar/data/1816815/000149315225015913/form6-k.htm) filed 2025-09-29 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001816815), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Bon Natural Life Limited is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BON, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Bon Natural Life Limited - **Ticker**: BON - **Listing**: NASDAQ - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: KYG144922047 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-BON/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/bon-natural-life/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Bon Natural Life (BON) news: offering and buyback", 2026-10-31, https://aibio.space/companies/bon-natural-life/